Esterified Cholesterol Conjugates Enable LNP‐Mediated mRNA Delivery to the Blood–Brain Barrier Following Intravenous Administration
Open Access
- 23 August 2026
- journal article
- research article
- Published by Wiley in Advanced Materials
- Vol. 38 (59) , e74762
Abstract
The blood–brain barrier (BBB) plays a critical role in maintaining central nervous system homeostasis by regulating molecular and cellular exchange between the brain and peripheral circulation. While most delivery strategies focus on crossing the BBB, targeting brain endothelial cells directly may offer a complementary and more controlled alternative for therapeutic intervention. This study presents a ligand‐free lipid nanoparticle (LNP) platform that enables efficient mRNA delivery to the brain endothelium via systemic administration. A modular synthesis strategy was used to generate a chemically diverse library of cholesterol‐based lipids. Screening of 486 LNPs identified an optimized four‐component formulation consisting of C6O2B2 (novel cholesterol‐based lipid), DODAP, DSPC, and DMG‐PEG, which achieves high transfection efficiency in brain endothelial cells without the incorporation of free cholesterol or disruption of BBB integrity and function, such as those utilized in focused ultrasound (FUS) techniques. This BBB‐targeting LNP platform avoids neuronal and glial transfection, thereby offering a noninvasive, and scalable approach for cerebrovascular gene delivery. The work establishes a new class of cholesterol‐based lipids and provides a foundation for next‐generation RNA therapeutics targeting BBB‐associated diseases.Keywords
Funding Information
- National Institutes of Health
- National Institute of Biomedical Imaging and Bioengineering (R01EB025192)
- National Cancer Institute (R01CA269787)
This publication has 26 references indexed in Scilit:
- Delivering therapeutic RNA into the brain using extracellular vesiclesMolecular Therapy Nucleic Acids, 2024
- Brain Nucleic Acid Delivery and Genome Editing via Focused Ultrasound-Mediated Blood–Brain Barrier Opening and Long-Circulating NanoparticlesACS Nano, 2024
- Synthesis of Lipidated Ligands and Formulation of Glia-Specific LNPs for RNAi-Mediated BBB ProtectionJournal of Medicinal Chemistry, 2024
- Targeting lipid nanoparticles to the blood-brain barrier to ameliorate acute ischemic strokeMolecular Therapy, 2024
- The interplay of quaternary ammonium lipid structure and protein corona on lung-specific mRNA delivery by selective organ targeting (SORT) nanoparticlesJournal of Controlled Release, 2023
- Lipid nanoparticle-mediated drug delivery to the brainAdvanced Drug Delivery Reviews, 2023
- Targeted drug delivery to the brain endothelium dominates over passive delivery via vascular leak in experimental intracerebral hemorrhageJournal of Controlled Release, 2023
- Focused ultrasound/microbubbles-assisted BBB opening enhances LNP-mediated mRNA delivery to brainJournal of Controlled Release, 2022
- Targeted Delivery of siRNA Lipoplexes to Cancer Cells Using Macrophage Transient Horizontal Gene TransferAdvanced Science, 2019
- The development of an in vitro assay to screen lipid based nanoparticles for siRNA deliveryJournal of Controlled Release, 2014